共 50 条
[37]
Do Health Technology Assessment organisations consider manufacturers’ costs in relation to drug price? A study of reimbursement reports
[J].
Cost Effectiveness and Resource Allocation,
20
[39]
Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe
[J].
Orphanet Journal of Rare Diseases,
15